Topic: Biotech

Dr. Moira Gunn talks with sleep experts, Bernard Pécoul Executive Director at DNDi and Yves Ribeill, CEO for Scynexis, about their work and the development of a drug for sleeping sickness.

Dr. Moria Gunn talks about the trend of building a global medical team in order to make better health care decisions with IDBS' Vice President of Corporate Development, Chris Molloy.

Dr. Moira Gunn talks first with Ann Bowering from the Venture Securities Exchange, which trades clean tech, biotech and the life sciences stock in the Asia market. Then she chats with Roger Stroud, Executive Chairman of Algae.Tec Limited, about turning algae into jet fuel.

Dr. Moira Gunn talks about nano-capsules, 100 times smaller than a blood cell, and their uses in a unique drug delivery system for cancer with the CEO of Epitarget, Esben Nilssen.

Dr. Moira Gunn discusses everything from a new approach to producing ethanol for our cars to an innovative approach to treating Mesothelioma with CEO Geoff Bell from MicroBioGen and David Lloyd, Dean of Research at Trinity College in Dublin.

Dr. Moira Gunn talks about how intellectual property rights in the age of personalized medicine with head of the Life Sciences Practice at Baker Botts, Jen Gordon.

Dr. Moira Gunn discusses generic drugs in the biotech space called biosimilars with Group Commercial Director for Eden BioDesign, Roger Lias.

Dr. Moira Gunn talks with Director Orin Levine from The International Vaccine Access Center at Johns-Hopkins School of Medicine about The Gavi Alliance and vaccines for the poor.

Dr. Moira Gunn talks about an exciting breakthrough in the treatment of trauma to the brain with the President and CEO of Edge Therapeutics, Brian Leuthner.

Dr. Moira Gunn discusses the war on counterfeit pharmaceuticals with the Head of Quality at Amgen, Martin VanTreste.